Ethics review in compassionate use-Reference-Cited by-同舟云学术

Ethics review in compassionate use

Published:2017-07-24 Issue:1 Volume:15 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Borysowski Jan,Ehni Hans-Jörg,Górski Andrzej

Funder

Warszawski Uniwersytet Medyczny

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-017-0910-9.pdf

Reference39 articles.

1. Nardini C. The ethics of clinical trials. Ecancermedicalscience. 2014;8:387.

2. Mackey TK, Schoenfeld VJ. Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access. BMC Med. 2016;14:17.

3. Calandra GB, Garelik JP, Kohler PT, Brown KR. Problems and benefits of an antibiotic compassionate therapy program. Rev Infect Dis. 1987;9:1095–101.

4. Caplan AL, Bateman-House A. Should patients in need be given access to experimental drugs? Expert Opin Pharmacother. 2015;16:1275–9.

5. US Food and Drug Administration. Expanded access (compassionate use). 2017. http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ , Accessed 04 July 2017.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O;Clinical Drug Investigation;2024-07-20

2. Accelerating the establishment of management systems for compassionate use in China;Drug Discovery Today;2024-07

3. Eksperymentalne terapie – definicje i regulacje;Diametros;2023-12-20

4. Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials;Frontiers in Pharmacology;2023-12-15

5. If it walks like a duck…: Monitored Emergency Use of Unregistered and Experimental Interventions (MEURI) is research;Journal of Medical Ethics;2023-11-23